Who are the peers of the Parnax Lab?
Parnax Lab's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. Parnax Lab has below average management and capital structure risks, with a 1-year return of 11.79%, lower than Divi's Lab's 51.69% but higher than Bharat Immunolog's -9.56%.
Peers: The peers of Parnax Lab are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Source Natural, Bharat Immunolog, Samrat Pharma, Mercury Labs, and Ajooni Biotech.Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Samrat Pharma, while Good management risk is found at Divi's Lab., Torrent Pharma, Source Natural, and Mercury Labs. Below Average management risk is noted for Parnax Lab, Bharat Immunolog, and Ajooni Biotech. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Good growth is seen at Parnax Lab. Below Average growth is found at Divi's Lab., Torrent Pharma, Source Natural, Bharat Immunolog, Samrat Pharma, Mercury Labs, and Ajooni Biotech. Excellent capital structure is present in Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Mercury Labs, while Good capital structure is noted for Torrent Pharma and Samrat Pharma. Below Average capital structure is observed at Parnax Lab, Divi's Lab., Bharat Immunolog, and Ajooni Biotech.
Return Snapshot: The peer with the highest 1-year return is Divi's Lab. at 51.69%, while Bharat Immunolog has the lowest at -9.56%. Parnax Lab's 1-year return is 11.79%, which is higher than Bharat Immunolog's but lower than Divi's Lab.'s. Additionally, the six-month return is negative for Parnax Lab, Source Natural, Mercury Labs, and Ajooni Biotech.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
